Medical Xpress October 10, 2024
Louise Vennells, University of Exeter

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded.

Mounting evidence suggests that hydrogen sulfide plays an important role in the liver. Previous research shows that tiny amounts of hydrogen sulfide in the body regulate how the liver processes fat, but up until recently, there has been no way to do that specifically. It also impacts the function of mitochondria, known as the “powerhouse” of cells, which generate energy.

The new study is led by Jagiellonian University Medical College in Poland and the University of Exeter and published in Pharmacological Research. For the study, mice who were fed a were injected with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
The weight loss drug revolution is shrinking America's waistline
2024’s Biggest Weight Loss Drug Stories
Genomics-informed model beneficial for neurodevelopmental disorders
Drugmakers plan price hikes for 250+ medications in 2025: Reuters
How a duty to spend wisely on worker benefits could loosen PBMs' grip on drug prices

Share This Article